Filippucci E, Aydin S Zehra, Karadag O, Salaffi F, Gutierrez M, Direskeneli H, Grassi W
Rheumatology Department, Università Politecnica delle Marche, 60035 Jesi (Ancona), Italy.
Ann Rheum Dis. 2009 Dec;68(12):1850-5. doi: 10.1136/ard.2008.096511. Epub 2009 Apr 8.
The present study was mainly aimed at investigating the interobserver and intraobserver reproducibility of ultrasound (US) results in the assessment of Achilles tendon enthesopathy in patients with seronegative spondyloarthropathies (SpA).
A total of 28 patients with a diagnosis of SpA according to the European Spondyloarthropathy Study Group criteria were included. The patient female/male ratio was 1.8 (18/10), mean age was 42 (range 25-75) years and mean disease duration was 9 (range 1-35) years. Mean (SD) Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) and Bath Ankylosing Spondylitis Functional Index (BASFI) scores were 32.4 (14.5) and 26.3 (9.2), respectively. Bilateral Achilles tendon US examinations were carried out independently by three investigators using a MyLab70 XVG (Esaote Biomedica, Genoa, Italy), equipped with a broadband 6-18 MHz linear probe. Each Achilles tendon was scanned for assessing the presence/absence of US findings indicative of enthesopathy according to the Outcome Measures in Rheumatoid Arthritis Clinical Trials (OMERACT) preliminary definition. The same findings were also scored on a 3-grade semiquantitative scoring system on which investigators reached a consensus prior to the study. Total additive scores per Achilles tendon were calculated.
Moderate to excellent interobserver and intraobserver agreements were found for most of the US findings indicative of enthesopathy. Similar results were obtained using semiquantitative assessments, with weighted kappa values estimating the interobserver and intraobserver agreements for soft tissue inflammation of 0.696 and 0.816, respectively and for tissue damage 0.711 and 0.901, respectively.
US assessment of Achilles tendon enthesopathy in patients with SpA, using the OMERACT preliminary definition, was found to be reliable. Bone irregularity and entheseal hypoechogenicity were the most difficult abnormalities to reach agreement on.
本研究主要旨在调查超声(US)结果在评估血清阴性脊柱关节病(SpA)患者跟腱附着点病方面的观察者间和观察者内可重复性。
纳入了28例根据欧洲脊柱关节病研究组标准诊断为SpA的患者。患者的女性/男性比例为1.8(18/10),平均年龄为42岁(范围25 - 75岁),平均病程为9年(范围1 - 35年)。平均(标准差)巴斯强直性脊柱炎疾病活动指数(BASDAI)和巴斯强直性脊柱炎功能指数(BASFI)评分分别为32.4(14.5)和26.3(9.2)。由三名研究人员使用配备宽带6 - 18 MHz线性探头的MyLab70 XVG(意大利热那亚的百胜医疗集团)独立进行双侧跟腱超声检查。根据类风湿关节炎临床试验结果测量(OMERACT)初步定义,对每条跟腱进行扫描以评估是否存在提示附着点病的超声表现。同样的表现也根据一个3级半定量评分系统进行评分,研究人员在研究前就此达成了共识。计算每条跟腱的总加分。
对于大多数提示附着点病的超声表现,观察者间和观察者内一致性为中度至高度。使用半定量评估也获得了类似结果,加权kappa值估计观察者间和观察者内软组织炎症的一致性分别为0.696和0.816,组织损伤的一致性分别为0.711和0.901。
使用OMERACT初步定义,超声评估SpA患者的跟腱附着点病是可靠的。骨不规则和附着点低回声是最难达成一致的异常表现。